Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EPP | 45.39 | 0.85 | +1.91% |
| iShares MSCI Pacific ex Japan ETF | |||
| IBHI | 23.08 | 0.21 | +0.94% |
| iShares iBonds 2029 Term HY & Inc ETF | |||
| RPHS | 9.62 | 0.07 | +0.79% |
| Regents Park Hedged Market Strategy ETF | |||
| MDIV | 15.80 | 0.09 | +0.57% |
| Multi-Asset Diversified Income ETF | |||
| FPXE | 26.37 | N/A | N/A |
| First Trust IPOX Europe Equity Opps ETF | |||
A.I.dvisor tells us that BEIGF and GOVX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BEIGF and GOVX's prices will move in lockstep.
| Ticker / NAME | Correlation To BEIGF | 1D Price Change % | ||
|---|---|---|---|---|
| BEIGF | 100% | N/A | ||
| GOVX - BEIGF | 29% Poorly correlated | +17.92% | ||
| CING - BEIGF | 29% Poorly correlated | +2.12% | ||
| CMRX - BEIGF | 27% Poorly correlated | N/A | ||
| POLBF - BEIGF | 25% Poorly correlated | N/A | ||
| TSVT - BEIGF | 11% Poorly correlated | N/A | ||
More | ||||